Antihypertensive effects of DL-tetrahydropalmatine: An active principle isolated from Corydalis

1. The effects of DL-tetrahydropalmatine (DL-THP) on cardiovascular function and hypothalamic release of monoamines were assessed in rats under urethane anaesthesia. 2. Intravenous administration of DL-THP (1-10 mg/kg) produced hypotension, bradycardia, a decrease in hypothalamic serotonin and noradrenaline release and an increase in hypothalamic dopamine release in rats. 3. Intrahypothalamic administration of DOI (a serotonergic 5-HT2 receptor antagonist) or apomorphine (a dopamine D-2-receptor agonist) produced the opposite effects and reversed DL-THP-induced hypotension and bradycardia. 4. The data suggest that DL-THP acts through the 5-HT2 and/or D-2-receptor antagonism in the hypothalamus to induce hypotension and bradycardia in rats.